Local Anesthesia Drugs Market Size, Share, Growth and Trends, 2018 to 2025
by Susan Hill Business ConsultantThe global local
anesthesia drugs market size is anticipated to reach USD 6.45 billion by 2025, according to
a new report by Grand View Research, Inc., registering a 3.7% CAGR during the
forecast period. Rising number of surgical procedures across the globe,
including cosmetic
surgeries, dental procedures, and plastic surgeries, is driving the growth
of local anesthetics.
There has been a considerable increase in number of
surgical procedures requiring post-operative pain relief and this trend is
expected to continue throughout the forecast period. Roughly, 65.0% of total
surgical procedures require post-operative pain management. This is likely to
boost the demand for local anesthesia drugs.
Introduction of new and effective drugs such as
levobupivacaine, articaine, and ropivacaine is also driving the growth of the
local anesthesia drugs market across the globe. Rising healthcare expenditure
in developing countries is expected to result in an increase in number of
surgeries performed in countries such as India, China, and Brazil. This is
likely to contribute to market growth in the region.
Further
key findings from the study suggest:
- Lidocaine dominated the market by product as of 2016 owing to its
extensive use as topical and injectable anesthetic
- By application, the market is bifurcated into injectable and surface
anesthetic. The injectable segment is expected to dominate the local
anesthesia drugs market during the forecast period owing to extensive
usage in different surgical procedures. Advancements in drug delivery
systems is expected to drive the market for surface anesthetics over the
forecast period
- North America held the largest share in the market for local
anesthesia drugs owing to significant number of surgical procedures
performed in the region
- Some of the key players are Aspen Pharmacare; Fresenius Kabi;
Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and
Teva Pharmaceuticals.
Grand View Research has segmented the global local
anesthesia drugs market on the basis of product, application, and region:
Local
Anesthesia Drugs Product Outlook (Revenue, USD Million, 2014 - 2025)
- Bupivacaine
- Ropivacaine
- Lidocaine
- Chloroprocaine
- Prilocaine
- Benzocaine
- Other local anesthetics
Local
Anesthesia Drugs Application Outlook (Revenue, USD Million, 2014 - 2025)
- Injectable
- Surface Anesthetic
Local
Anesthesia Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
Access
full research report on global local anesthesia drugs market:
https://www.grandviewresearch.com/industry-analysis/local-anesthesia-drugs-market
Sponsor Ads
Created on Jun 27th 2019 04:46. Viewed 190 times.